Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Ovarian Neoplasms 9Breast Neoplasms 9Fallopian Tube Neoplasms 5Carcinoma, Ovarian Epithelial 5Squamous Cell Carcinoma of Head and Neck 4Triple Negative Breast Neoplasms 3Neoplasm Metastasis 3Lung Neoplasms 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Carcinoma 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Non Small Cell Lung Carcinoma NSCLC 2Neoplasms, Unknown Primary 2Neoplasms 2NSCLC 2Melanoma 2Esophageal Neoplasms 2Adenocarcinoma 2Urologic Neoplasms 1Urogenital Neoplasms 1Unresectable Stage III NSCLC 1Triple Negative Metastatic Breast Cancer 1Thyroid Neoplasms 1Thrombocytopenia 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1

Interventions

Cisplatin 274pembrolizumab 229Radiotherapy 166Cetuximab 163Carboplatin 122Docetaxel 109Paclitaxel 94Fluorouracil 94Nivolumab 84Radiotherapy, Intensity-Modulated 78Magnetic Resonance Spectroscopy 39durvalumab 35Radiation 32Surgical Procedures, Operative 31Drug Therapy 30Radiosurgery 25Erlotinib Hydrochloride 25Biopsy 25Albumin-Bound Paclitaxel 24130-nm albumin-bound paclitaxel 24Taxes 23Platinum 22Specimen Handling 21tislelizumab 201,2-diaminocyclohexaneplatinum II citrate 20Cyclophosphamide 19Capecitabine 19tremelimumab 18Ipilimumab 18Gemcitabine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Squamous Cell Carcinoma of Head and Neck × CP protocol × Clear all
NCT05294900 2026-05-26

NEOS

Yonsei University

Phase 2 Completed
79 enrolled 6 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06062602 2023-10-06

PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC

Presage Biosciences

Phase EARLY_PHASE1 Completed
15 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05992610 2023-08-15

iCHRTL

Maria Sklodowska-Curie National Research Institute of Oncology

Phase NA Unknown
40 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

AstraZeneca

Phase 1 Completed
32 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡